Zdrowie i gospodarka · 11/02/2008
FDA Releases Draft Guidance for Sterility Testing of Cellular and Gene Therapy Products
The FDA has made available a draft document outlining recommendations for validating growth-based rapid microbiological methods for sterility testing of cellular and gene therapy products, which applies to somatic cellular therapy and gene therapy products.
Source: Federal Register — Food and Drug AdministrationOpen original release →